Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary

Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Ralph A Defronzo, Daniel Einhorn, Vivian A. Fonseca, Jeffrey R. Garber, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez

Research output: Contribution to journalReview article

179 Citations (Scopus)

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

Original languageEnglish (US)
Pages (from-to)91-120
Number of pages30
JournalEndocrine Practice
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Endocrinology
Type 2 Diabetes Mellitus
Consensus
Committee Membership
Randomized Controlled Trials
Endocrinologists

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary. / Garber, Alan J.; Abrahamson, Martin J.; Barzilay, Joshua I.; Blonde, Lawrence; Bloomgarden, Zachary T.; Bush, Michael A.; Dagogo-Jack, Samuel; Defronzo, Ralph A; Einhorn, Daniel; Fonseca, Vivian A.; Garber, Jeffrey R.; Garvey, W. Timothy; Grunberger, George; Handelsman, Yehuda; Hirsch, Irl B.; Jellinger, Paul S.; McGill, Janet B.; Mechanick, Jeffrey I.; Rosenblit, Paul D.; Umpierrez, Guillermo E.

In: Endocrine Practice, Vol. 24, No. 1, 01.01.2018, p. 91-120.

Research output: Contribution to journalReview article

Garber, AJ, Abrahamson, MJ, Barzilay, JI, Blonde, L, Bloomgarden, ZT, Bush, MA, Dagogo-Jack, S, Defronzo, RA, Einhorn, D, Fonseca, VA, Garber, JR, Garvey, WT, Grunberger, G, Handelsman, Y, Hirsch, IB, Jellinger, PS, McGill, JB, Mechanick, JI, Rosenblit, PD & Umpierrez, GE 2018, 'Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary', Endocrine Practice, vol. 24, no. 1, pp. 91-120. https://doi.org/10.4158/CS-2017-0153
Garber, Alan J. ; Abrahamson, Martin J. ; Barzilay, Joshua I. ; Blonde, Lawrence ; Bloomgarden, Zachary T. ; Bush, Michael A. ; Dagogo-Jack, Samuel ; Defronzo, Ralph A ; Einhorn, Daniel ; Fonseca, Vivian A. ; Garber, Jeffrey R. ; Garvey, W. Timothy ; Grunberger, George ; Handelsman, Yehuda ; Hirsch, Irl B. ; Jellinger, Paul S. ; McGill, Janet B. ; Mechanick, Jeffrey I. ; Rosenblit, Paul D. ; Umpierrez, Guillermo E. / Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary. In: Endocrine Practice. 2018 ; Vol. 24, No. 1. pp. 91-120.
@article{8f98e0897a884b489287e2ca0abc580c,
title = "Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary",
abstract = "This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.",
author = "Garber, {Alan J.} and Abrahamson, {Martin J.} and Barzilay, {Joshua I.} and Lawrence Blonde and Bloomgarden, {Zachary T.} and Bush, {Michael A.} and Samuel Dagogo-Jack and Defronzo, {Ralph A} and Daniel Einhorn and Fonseca, {Vivian A.} and Garber, {Jeffrey R.} and Garvey, {W. Timothy} and George Grunberger and Yehuda Handelsman and Hirsch, {Irl B.} and Jellinger, {Paul S.} and McGill, {Janet B.} and Mechanick, {Jeffrey I.} and Rosenblit, {Paul D.} and Umpierrez, {Guillermo E.}",
year = "2018",
month = "1",
day = "1",
doi = "10.4158/CS-2017-0153",
language = "English (US)",
volume = "24",
pages = "91--120",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "1",

}

TY - JOUR

T1 - Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary

AU - Garber, Alan J.

AU - Abrahamson, Martin J.

AU - Barzilay, Joshua I.

AU - Blonde, Lawrence

AU - Bloomgarden, Zachary T.

AU - Bush, Michael A.

AU - Dagogo-Jack, Samuel

AU - Defronzo, Ralph A

AU - Einhorn, Daniel

AU - Fonseca, Vivian A.

AU - Garber, Jeffrey R.

AU - Garvey, W. Timothy

AU - Grunberger, George

AU - Handelsman, Yehuda

AU - Hirsch, Irl B.

AU - Jellinger, Paul S.

AU - McGill, Janet B.

AU - Mechanick, Jeffrey I.

AU - Rosenblit, Paul D.

AU - Umpierrez, Guillermo E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

AB - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

UR - http://www.scopus.com/inward/record.url?scp=85044526898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044526898&partnerID=8YFLogxK

U2 - 10.4158/CS-2017-0153

DO - 10.4158/CS-2017-0153

M3 - Review article

VL - 24

SP - 91

EP - 120

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 1

ER -